Barriers to and new approaches for gene therapy and gene delivery in cystic fibrosis
Authors:
- Stefano FerrariSFStefano Ferrari
- Duncan M GeddesDGDuncan M Geddes
- Eric W.F.W AltonEAEric W.F.W Alton
- 1 December 2002
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 54 (11) , 1373-1393
Abstract
No abstract availableKeywords
This publication has 127 references indexed in Scilit:
- Development of Novel Formulations That Enhance Adenoviral-Mediated Gene Expression in the Lung in Vitro and in VivoMolecular Therapy, 2001
- High and Sustained Transgene Expression in Vivo from Plasmid Vectors Containing a Hybrid Ubiquitin PromoterMolecular Therapy, 2001
- Adeno-Associated Virus Type 2-Mediated Gene Transfer: Altered Endocytic Processing Enhances Transduction Efficiency in Murine FibroblastsJournal of Virology, 2001
- Repair of CFTR mRNA by spliceosome-mediated RNA trans-splicingGene Therapy, 2000
- Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virusJournal of Clinical Investigation, 2000
- G-protein-coupled receptors as targets for gene transfer vectors using natural small-molecule ligandsNature Biotechnology, 2000
- Expression of the human CFTR gene from episomal oriP-EBNA1-YACs in mouse cellsHuman Molecular Genetics, 2000
- A low rate of cell proliferation and reduced DNA uptake limit cationic lipid-mediated gene transfer to primary cultures of ciliated human airway epitheliaGene Therapy, 1997
- A second dose of a CFTR cDNA–liposome complex is as effective as the first dose in restoring cAMP-dependent chloride secretion to null CF mice tracheaGene Therapy, 1997
- HVJ (Sendai virus)-cationic liposomes: a novel and potentially effective liposome-mediated technique for gene transfer to the airway epitheliumGene Therapy, 1997